Velleja Research

Velleja Research specializes in the scientific development of new products for pharmaceutical, nutraceutical, cosmetic sectors and medical devices. The company has a track record of developing numerous preparations now marketed by various trading companies. It conducts research from active ingredient analysis through formulation development to clinical assessment/publication. Notable innovations include cannabinoid oil formulations and fibrinolytic compositions.

No direct evidence of large-scale pivotal clinical trials or late-stage drug assets; focus appears on early-to-mid-stage product innovation and B2B partnerships.

Key patents include novel cannabinoid oil solutions, oral fibrinolytic compositions for thrombosis prevention/treatment, specialized Ginkgo biloba extracts.

Products are often commercialized by partner/trading companies rather than under the Velleja brand itself.

Scientific leadership includes Dr. Francesco Di Pierro—biologist/pharmacologist with extensive publication/patent history.

Company operates both as an innovator/developer and as a consultancy/R&D provider.